Autosomal Recessive Hypophosphatemic Rickets Type 2 Associated with a Novel ENPP1 Variant in a Taiwanese Girl
PDF
Cite
Share
Request
Case Report
VOLUME: ISSUE:
P: -

Autosomal Recessive Hypophosphatemic Rickets Type 2 Associated with a Novel ENPP1 Variant in a Taiwanese Girl

1. Department of Pediatrics, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan
2. Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
3. Department of Pediatrics, National Taiwan University Hospital Yunlin Branch, Douliu, Yunlin, Taiwan
4. Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei, Taiwan
5. Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
No information available.
No information available
Received Date: 30.04.2024
Accepted Date: 08.06.2024
PDF
Cite
Share
Request

Abstract

Autosomal recessive hypophosphatemic rickets (HR) type 2 (ARHR2) is a rare form of HR caused by variant of the gene encoding ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). Our patient presented with a history of unsteady gait and progressively bowing legs that had commenced at the age of 1 year. Laboratory tests revealed an elevated level of fibroblast growth factor 23 (FGF23), hypophosphatemia, and a high urine phosphate level. Radiography revealed the typical features of rickets. Next-generation sequencing identified a previously reported c.783C>G (p.Tyr261Ter) and a novel c.1092-42A>G variant in the ENPP1 gene. The patient was prescribed oral phosphates and active vitamin D and underwent guided growth of both distal femora and proximal tibiae commencing at the age of 3 years. No evidence of generalized arterial calcification was apparent during follow-up, and growth rate was satisfactory.

Keywords:
Encoding ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), Fibroblast growth factor 23 (FGF23), Hypophosphatemic rickets